您的当前位置:首页 > 行业数据 > 图表61中国司美格鲁肽申报上市格局
图片属性
图片格式:PNG 图片大小:224KB 图片尺寸:1801*1406
同报告图片
 / 4
图表61中国司美格鲁肽申报上市格局_第1页
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
图表61中国司美格鲁肽申报上市格局_第2页
fCDlubTku70gfCDogqHmga/njocgfAp8LS0tLS0tfC0tLS0tLS0tfAp8IDIwMTAgfCAwLjIlICAgfAp8IDIwMTEgfCAyLjQlICAgfAp8IDIwMTIgfCAxLjQlICAgfAp8IDIwMTMgfCAxLjMlICAgfAp8IDIwMTQgfCAwLjIlICAgfAp8IDIwMTUgfCAwLjklICAgfAp8IDIwMTYgfCAwLjglICAgfAp8IDIwMTcgfCAzLjAlICAgfAp8IDIwMTggfCA0LjglICAgfAp8IDIwMTkgfCAzLjQlICAgfAp8IDIwMjAgfCAzLjElICAgfAp8IDIwMjEgfCAzLjIlICAgfAp8IDIwMjIgfCA0LjklICAgfAp8IDIwMjMgfCAzLjklICAgfAp8IDIwMjQgfCAzLjAlICAgfAoK6LWE5paZ5p2l5rqQ77yaV2luZO+8jOWNjuWIm+ivgeWIuO+8iOaIquiHszIwMjYvMi8yOO+8iQ==
图表61中国司美格鲁肽申报上市格局_第3页
图表61中国司美格鲁肽申报上市格局_第4页
图表61中国司美格鲁肽申报上市格局_第5页
所属报告: 丽珠集团(000513)-A股公司深度研究报告:创新转型收获国产制药领导者迎新阶段-260313(47页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠